Media Room
First Quarter 2025
First quarter 2025 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session.
Thursday April 24, 2025
13:00 - 14:30 CEST (7:00am – 8:30am EDT)
Press releases
April 18, 2025
Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria
April 15, 2025
Press Release: Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD
April 8, 2025
Press Release: Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
Contact Our Media Team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
Publications
Sustainability Statement 2024 (ESG Report)
XBRL Viewer URD 2024
Registration Document 2024 (in French)
XBRL Viewer 20F 2024